A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection-Reference-Cited by-同舟云学术

A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection

Published:2020-09-01 Issue:3 Volume:184 Page:861-872
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Nietz Sarah,O’Neil Daniel S^ORCID,Ayeni Oluwatosin,Chen Wenlong Carl,Joffe Maureen,Jacobson Judith S,Neugut Alfred I,Ruff Paul,Mapanga Witness,Buccimazza Ines,Singh Urishka,Čačala Sharon,Stopforth Laura,Phakathi Boitumelo,Chirwa Tobias,Cubasch Herbert

Funder

National Cancer Institute

South African Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-020-05889-8.pdf

Reference67 articles.

1. Harrison K, Song R, Zhang X (2010) Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. JAIDS J Acquir Immune Defic Syndr 53:124–130. https://doi.org/10.1097/QAI.0b013e3181b563e7

2. Siddiqi A-A, Irene Hall H, Hu X, Song R (2016) Population-based estimates of life expectancy after hiv diagnosis United States 2008–2011. J Acquir Immune Defic Syndr 72:230–236. https://doi.org/10.1097/QAI.0000000000000960